Once identified as vulnerable, applicants enjoy specific rights and safeguards in the asylum process under EU law. Vulnerability should therefore trigger additional or tailored support to ensure that people have the necessary conditions to bring forward a claim for protection.
Census Report Volume 4-E
As no census has been undertaken in over 30 years, many aspects of the demographic situation in the country were unknown. For instance, before the Census it was thought that the country had a population of about 60 million, but the 2014 Census showed that the population... (including an estimate for under-enumeration) was 51,486,253 persons, around 8.5 million less than the previous estimate.
In the 1983 census, 35,307,913 persons were recorded. Therefore between 1983 and 2014, the population increased by 46 per cent. With an average annual population growth rate of 0.89 per cent between 2003 and 2014, Myanmar is one of the slowest growing countries in Southeast Asia.
more
Transforming Health: Accelerating attainment of Health Goals | THE SECOND MEDIUM TERM PLAN FOR HEALTH
This new guideline on non-clinical interventions to reduce unnecessary caesarean sections incorporates the views, fears and beliefs of both women and health professionals about caesarean sections. It also considers the complex dynamics and limitations of health systems and organizations and relation...ships between women, health professionals and organization of health care services.
more
The only way to prevent future Ebola epidemics of this magnitude is to address the fundamental social and political vulnerabilities that have allowed the virus to flourish, such as weak health systems and local services, poor governance, chronic poverty, and a legacy of conflict and social divisions
Response to the tropical cyclone in southern Africa
Ebola virus disease outbreak in the Democratic Republic of the Congo
Meningitis outbreak in Togo
Lassa fever outbreak in Liberia.
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.